George Davis

George Davis, PharmD, serves as an Adjunct Professor in the Department of Pharmacy Practice and Science at the University of Kentucky College of Pharmacy and as Antithrombosis Stewardship Program Coordinator at UK HealthCare Pharmacy Services. With over 25 years of clinical pharmacy experience at UK HealthCare, his work spans practice, teaching, research, and scholarly activities focused on optimizing antithrombotic therapies and clinical pharmacokinetics.

His educational background includes:

• Doctor of Pharmacy from the University of Arkansas for Medical Sciences College of Pharmacy
• PGY1 Pharmacy Practice Residency at UK Healthcare
• PGY2 Pharmacy Practice Residency in Clinical Pharmacokinetics at UK Healthcare
• Academic Fellowship in Geriatric Drug Therapy at the University of Kentucky College of Pharmacy

Dr. Davis's research centers on clinical pharmacokinetics and antithrombosis pharmacotherapeutics, with specialized expertise in anticoagulation stewardship, pulmonary embolism management, and venous thromboembolism prevention. His work integrates pharmacy practice with cardiology through multidisciplinary collaboration, particularly in the development and implementation of antithrombosis consult services and quality assurance protocols. He actively shapes national standards as a member of the Pulmonary Embolism Response Team (PERT) Consortium Board of Directors.

Analysis of his 2020-2024 publications reveals dominant themes in pulmonary embolism management strategies, anticoagulation safety during pandemics, and value-based assessment of thrombosis care teams. His work demonstrates consistent focus on pharmacist-led interventions, reversal of anticoagulant-related bleeding, and real-world implementation of clinical guidelines across diverse healthcare settings.

Dr. Davis co-leads UK HealthCare's multidisciplinary Pulmonary Embolism Response Team (PERT) and contributes to national initiatives through the PERT Consortium's Education, Protocol Development, and Research committees. His clinical leadership extends to anticoagulation stewardship program coordination, encompassing formulary management, safety protocols, and quality improvement initiatives for antithrombotic therapies.